Procurement of Drugs for Indian Navy
Indian Navy · Kochi · Pharmaceuticals · open
Key facts
- Tender value: ₹1.4L
- Published: 12 Aug 2026
- Closing date: 22 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for procurement of multiple drugs including Upadacitinib, Apremilast, Lenalidomide, Testoviron, and Tirzepatide, with a total quantity of 592 units, issued by the Indian Navy under the Ministry of Defence, Department of Military Affairs. The bid is open from August 12, 2026, to August 22, 2026, with a validity of 180 days from the end date.
Eligibility & requirements
- Past performance: 10%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: OEM Authorization Certificate, OEM Annual Turnover, Past Performance Certificate, Supporting documents for experience and turnover exemption
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (5)
- Upadacitinib 15mg — Qty: 270 Tablet
- Apremilast 20mg — Qty: 270 Tablet
- Lenalidomide 25mg — Qty: 52 Capsule
- Testoviron 250mg — Qty: 0 Injection
- Tirzepatide 5mg — Qty: 0 Injection
1 tender document(s) available — sign up to download.